Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,117 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Anoikis-suppression and invasion induced by tyrosine kinase receptor B in OVCAR3 ovarian cancer cells].
Yu XH, Yang YX, Cai B, Yan Q, He YY, Wan XP. Yu XH, et al. Among authors: yan q. Zhonghua Fu Chan Ke Za Zhi. 2008 Sep;43(9):695-9. Zhonghua Fu Chan Ke Za Zhi. 2008. PMID: 19087522 Chinese.
[Establishment of the model of heterotopic uterine transplantation in syngeneic rats].
Yan Q, Wan XP, He XY, Xi XW, Yang YX. Yan Q, et al. Zhonghua Fu Chan Ke Za Zhi. 2005 May;40(5):291-4. Zhonghua Fu Chan Ke Za Zhi. 2005. PMID: 15938774 Chinese.
[Analysis surgical results of 113 patients with complete transposition of the great arteries].
Xu ZW, Liu JF, Zhang HB, Zheng JH, Yan Q, Qiu LS, Wang SM, Su ZK, Ding WX. Xu ZW, et al. Among authors: yan q. Zhonghua Wai Ke Za Zhi. 2007 Jun 15;45(12):801-4. Zhonghua Wai Ke Za Zhi. 2007. PMID: 17845774 Chinese.
Link of Dlk/ZIP kinase to cell apoptosis and tumor suppression.
Wu Y, Yan Q, Zuo J, Saiyin H, Jiang W, Qiao S, Yu L. Wu Y, et al. Among authors: yan q. Biochem Biophys Res Commun. 2010 Feb 19;392(4):510-5. doi: 10.1016/j.bbrc.2010.01.054. Epub 2010 Jan 18. Biochem Biophys Res Commun. 2010. PMID: 20085750
MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo.
Jiang F, Liu T, He Y, Yan Q, Chen X, Wang H, Wan X. Jiang F, et al. Among authors: yan q. BMC Cancer. 2011 Oct 5;11:425. doi: 10.1186/1471-2407-11-425. BMC Cancer. 2011. PMID: 21970405 Free PMC article.
Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.
Wu X, Yan Q, Zhang Z, Du G, Wan X. Wu X, et al. Among authors: yan q. Oncol Rep. 2012 May;27(5):1488-96. doi: 10.3892/or.2012.1670. Epub 2012 Feb 2. Oncol Rep. 2012. PMID: 22327423
Epigenetic inactivation of BRCA1 through promoter hypermethylation in ovarian cancer progression.
Wang YQ, Yan Q, Zhang JR, Li SD, Yang YX, Wan XP. Wang YQ, et al. Among authors: yan q. J Obstet Gynaecol Res. 2013 Feb;39(2):549-54. doi: 10.1111/j.1447-0756.2012.01979.x. Epub 2012 Sep 25. J Obstet Gynaecol Res. 2013. PMID: 23006047
Overexpression of p21-activated kinase 1 promotes endometrial cancer progression.
Lu W, Qu JJ, Li BL, Lu C, Yan Q, Wu XM, Chen XY, Wan XP. Lu W, et al. Among authors: yan q. Oncol Rep. 2013 Apr;29(4):1547-55. doi: 10.3892/or.2013.2237. Epub 2013 Jan 15. Oncol Rep. 2013. PMID: 23338047
EMX2 is downregulated in endometrial cancer and correlated with tumor progression.
Qiu H, Yan Q, Luo X, Zhang H, Bao W, Wan X. Qiu H, et al. Among authors: yan q. Int J Gynecol Pathol. 2013 Mar;32(2):193-8. doi: 10.1097/PGP.0b013e31825d8049. Int J Gynecol Pathol. 2013. PMID: 23370654
miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma.
Su N, Qiu H, Chen Y, Yang T, Yan Q, Wan X. Su N, et al. Among authors: yan q. Oncol Rep. 2013 Jun;29(6):2297-302. doi: 10.3892/or.2013.2400. Epub 2013 Apr 10. Oncol Rep. 2013. PMID: 23589079
3,117 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback